The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–240 of 240
Wang, J., Cai, Y., Dong, Y., Nong, J., Zhou, L., Liu, G., Su, D., Li, X., Wu, S., Chen, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101551 · Cited by 59
Clinical Implications of Variant ALK FISH Rearrangement Patterns
Gao, X., Sholl, L. M., Nishino, M., Heng, J. C., Janne, P. A., & Oxnard, G. R. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000665 · Cited by 59
Self-citationHan, J., Kim, S. H., Lee, Y.-S., Lee, S. Y., Hwang, J.-A., Kim, J. Y., Yoon, S. J., & Lee, G. K. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.04.009 · Cited by 58
Sasaki, H., Shimizu, S., Tani, Y., Shitara, M., Okuda, K., Hikosaka, Y., Moriyama, S., Yano, M., & Fujii, Y. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.06.014 · Cited by 50
An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients
Kawada, I., Soejima, K., Watanabe, H., Nakachi, I., Yasuda, H., Naoki, K., Kawamura, M., Eguchi, K., Kobayashi, K., & Ishizaka, A. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318186fadd · Cited by 50
Satouchi, M., Negoro, S., Funada, Y., Urata, Y., Shimada, T., Yoshimura, S., Kotani, Y., Sakuma, T., Watanabe, H., Adachi, S., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603710 · Cited by 49
Self-citationPiotrowska, Z., & Sequist, L. V. D. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000147 · Cited by 49
Lü, S., Ding, D., Yu, Y., Li, Z., & Niu, X. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s58870 · Cited by 48
High Efficacy of First-Line Gefitinib in Non-Asian Patients with EGFR-Mutated Lung Adenocarcinoma
Moiseyenko, V. M., Procenko, S. A., Levchenko, E., As, B., Moiseenko, F. V., Iyevleva, A. G., Mitiushkina, N. V., Togo, A. V., Semionov, I. I., Ivantsov, A. O., et al. (2010) · Onkologie · doi:10.1159/000302729 · Cited by 48
Tsai, T.-H., Wu, S., Hsieh, M., Yu, C., Yang, J. C., & Shih, J. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.02.018 · Cited by 47
Detection of EGFR Gene Mutations Using the Wash Fluid of CT-Guided Biopsy Needle in NSCLC Patients
Otani, H., Toyooka, S., Soh, J., Yamamoto, H., Suehisa, H., Kobayashi, N., Gobara, H., Mimura, H., Kiura, K., Sano, Y., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31816de2cd · Cited by 44
Wu, Y.-L. L. C., Yang, J. C., Kim, D., Su, W., Ahn, M., Lee, K. H., Vansteenkiste, J., Zhang, L., Felip, E., Peng, B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.8017 · Cited by 44
Huang, D., Kim, D., Kotsakis, A. P., Deng, S., Lira, P. D., Ho, S. N., Lee, N. V., Vizcarra, P., Cao, J. Q., Christensen, J. G., et al. (2013) · Genomics · doi:10.1016/j.ygeno.2013.02.006 · Cited by 43
Xu, J., Han, Y., Duan, H. Q., Gao, E., Zhang, Y., Liu, X., Zhang, J. S., Toschi, L., Galetta, D., Azzariti, A., et al. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0512-1 · Cited by 43
Harada, T., López-Chávez, A., Xi, L., Raffeld, M. A., Wang, Y., & Giaccone, G. (2010) · Oncogene · doi:10.1038/onc.2010.545 · Cited by 39
Ma, P. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0769 · Cited by 39
Kondo, M., Yokoyama, T., Fukui, T., Yoshioka, H., Yokoi, K., Nagasaka, T., Imaizumi, K., Kume, H., Hasegawa, Y., Shimokata, K., et al. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.06.008 · Cited by 38
Noro, R., Seike, M., Zou, F., Soeno, C., Matsuda, K., Sugano, T., Nishijima, N., Matsumoto, M., Kitamura, K., Kosaihira, S., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1019-1 · Cited by 33
Impact of HER2 and EGFR gene status on gefitinib‐treated patients with nonsmall‐cell lung cancer
Soh, J., Toyooka, S., Ichihara, S., Fujiwara, Y., Hotta, K., Suehisa, H., Kobayashi, N., Ichimura, K., Aoe, K., Aoe, M., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22818 · Cited by 33
Wei, Z., Shah, N., Deng, C., Xiao, X., Zhong, T., & Li, X. (2016) · SpringerPlus · doi:10.1186/s40064-016-2141-5 · Cited by 33
Li, Z., Zhang, Y., Bao, W., & Jiang, C. (2014) · Targeted Oncology · doi:10.1007/s11523-014-0312-2 · Cited by 32
Wu, J., Shih, J., Chen, K., Yang, C.-H., Yu, C., & Yang, P. (2011) · Medicine · doi:10.1097/md.0b013e31821a16f4 · Cited by 31
Álvarez, F. V., Trueba, I. M., Sanchis, J. B., López‐Rodó, L. M., Suárez, P. M. R., Escuín, J. S. D. C., Barreiro, E., Pintado, M. H. B., Vicente, C. D., Aldeyturriaga, J. F., et al. (2016) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2016.02.016 · Cited by 30
EGFR/KRAS Mutations and Gefitinib Therapy in Chinese NSCLC Patients
Wang, Z., Wu, Y.-L. L. C., Zhang, G. C., Zhou, Q., Xu, C., & Guo, A. (2008) · Onkologie · doi:10.1159/000116736 · Cited by 25
Felip, E., Concha, Á., de Castro, J., Gómez‐Román, J., Garrido, P., Ramírez, J., Isla, D., Sanz, J., Paz-Ares, L. G., & López‐Ríos, F. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1248-9 · Cited by 24
Shan, L., Qiu, T., Ling, Y., Guo, L., Zheng, B. J., Wang, B., Li, W., Li, L., & Ying, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130447 · Cited by 23
Weingertner, N., Meyer, N., Voegeli, A., et al. (2015) · Pathology · doi:10.1097/pat.0000000000000269 · Cited by 22
Cohen, V., Agulnik, J. S., Ang, C., Kasymjanova, G., Batist, G., Small, D. I., Brandao, G., Chong, G., & Miller, W. H. (2010) · Cancer · doi:10.1002/cncr.25214 · Cited by 22
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013
Camps, C., Felip, E., García‐Campelo, R., Trigo, J. M., & Garrido, P. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1085-2 · Cited by 22
Ding, D., Yu, Y., Li, Z., Niu, X., & Lu, S. (2014) · Dove Medical Press (Taylor and Francis Group) · Cited by 22
Guérin, A., Sasané, M., Zhang, J., Macalalad, A. R., Galebach, P., Jarvis, J. L., Kageleiry, A., Culver, K. W., Wu, E. Q., & Wakelee, H. A. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.04.005 · Cited by 20
Detecting the spectrum of multiplex gene mutations in non-small cell lung cancer by Snapshot assay
Su, J., Zhang, X., An, S., Zhong, W., Huang, Y., Chen, S., Yan, H., Chen, Z. H., Guo, W., Huang, X.-S., et al. (2014) · 癌症:英文版 · doi:10.5732/cjc.013.10195 · Cited by 20
Álvarez, F. V., Trueba, I. M., Sanchis, J. B., López‐Rodó, L. M., Suárez, P. M. R., Escuín, J. S. D. C., Barreiro, E., Pintado, M. H. B., Vicente, C. D., Aldeyturriaga, J. F., et al. (2016) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2016.02.020 · Cited by 19
Biological Marker Analysis as Part of the CIBERES-RTIC Cancer-SEPAR Strategic Project on Lung Cancer
Monsó, E., Montuenga, L. M., de Cos, J. S., & Villena, C. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2015.05.005 · Cited by 15
Canadian Consensus: Inhibition of Alk-Positive Tumours in Advanced Non-Small-Cell Lung Cancer
Melosky, B. L., Agulnik, J. S., Albadine, R., Banerji, S. O., Bebb, D. G., Bethune, D. C. G., Blais, N., Butts, C. A., Cheema, P. K., Cheung, P., et al. (2016) · Current Oncology · doi:10.3747/co.23.3120 · Cited by 13
Self-citationPopper, H., Gruber-Moesenbacher, U., Müllauer, L., Hutarew, G., Vesely, M., Pirker, R., Hilbe, W., Ploner, F., Setinek, U., Hulla, W., et al. (2013) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-013-0087-7 · Cited by 11
Kowalczuk, O., Kozłowski, M., Niklinska, W. E., Kiśluk, J., Niklińska, B., & Nikliński, J. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.08.002 · Cited by 10
Prognostic significance of the C-erbB-2 expression in turkish non-small cell lung cancer patients.
Çalıkuşu, Z., Yıldırım, Y., Akçalı, Z., et al. (2009) · PubMed · Cited by 6
Scheffler, M., Ihle, M. A., Hein, R., Merkelbach‐Bruse, S., Braegelmann, J., Scheel, A. H., Michels, S. Y. F., Ueckeroth, F., Eisert, A., Gogl, L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.9018 · Cited by 6
Popper, H., Gruber-Moesenbacher, U., Hutarew, G., Hochmair, M. J., Absenger, G., Brčić, L., Müllauer, L., Dekan, G., Setinek, U., Krenbek, D., et al. (2016) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-016-0297-x · Cited by 6
Cited by
Drilon, A., Siena, S., Dziadziuszko, R., Barlesi, F., Krebs, M. G., Shaw, A. T., de Braud, F., Rolfo, C., Ahn, M.-J., Wolf, J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30690-4 · Cited by 528
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Testa, U., Castelli, G., & Pelosi, E. (2018) · Cancers · doi:10.3390/cancers10080248 · Cited by 403
EGFR signaling pathway as therapeutic target in human cancers
Levantini, E., Maroni, G., Del Re, M., & Tenen, D. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.002 · Cited by 356
The current state of molecular testing in the treatment of patients with solid tumors, 2019
El‐Deiry, W. S., Goldberg, R. M., Lenz, H., Shields, A. F., Gibney, G. T., Tan, A. R., Brown, J., Eisenberg, B., Heath, E. I., Phuphanich, S., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21560 · Cited by 264
Metadata
- Authors
- Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B., Wynes, M. W., & Yatabe, Y.
- Venue
- The Journal of Molecular Diagnostics
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 20
- Issue
- 2
- Pages
- 129-159
- ISSN
- 1525-1578 (ISSN-L)
- OpenAlex
- W2785259638
- Cited by
- 346
- References
- 240
- FWCI
- 30.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.